These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6313539)

  • 41. Hormone receptor modulates the regulatory component of adenylyl cyclase by reducing its requirement for Mg2+ and enhancing its extent of activation by guanine nucleotides.
    Iyengar R; Birnbaumer L
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5179-83. PubMed ID: 6291028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of the trinitrophenylation of the amino groups of glucagon on its conformational properties and on its ability to activate rat liver adenylyl cyclase.
    Epand RM; Wheeler GE
    Biochim Biophys Acta; 1975 May; 393(1):236-46. PubMed ID: 237568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucagon stimulates adenylate cyclase through GR2 glucagon receptors: a process which can be attenuated by glucagon stimulating inositol phospholipid metabolism through GR1 glucagon receptors.
    Houslay MD; Wakelam MJ; Murphy GJ; Gawler DJ; Pyne NJ
    Biochem Soc Trans; 1987 Feb; 15(1):21-4. PubMed ID: 3030839
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanism of glucagon activation of adenylate cyclase in the presence of Mn2+.
    Houslay MD; Heyworth CM; Whetton AD
    FEBS Lett; 1983 May; 155(2):311-6. PubMed ID: 6303847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conformational and biological properties of a covalently linked dimer of glucagon. Reaction of mono- and bifunctional sulfenyl halides.
    Epand RM; Cote TE
    Biochim Biophys Acta; 1976 Dec; 453(2):365-73. PubMed ID: 999894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the interaction of glucagon, human parathyroid hormone-(1-34)-peptide and calcitonin with dimyristoylphosphatidylglycerol and with dimyristoylphosphatidylcholine.
    Epand RM; Epand RF; Orlowski RC; Flanigan E; Stahl GL
    Biophys Chem; 1985 Nov; 23(1-2):39-48. PubMed ID: 4092081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-function relationships of S-carboxymethyl methionine27 glucagon.
    Cornely KA; Shelter KA; England RD; Horwitz EM; Gurd RS
    Arch Biochem Biophys; 1985 Aug; 240(2):698-704. PubMed ID: 2992382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
    Robberecht P; Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers-Piret MC; Vandermeers A; Christophe J
    Eur J Biochem; 1992 Jul; 207(1):239-46. PubMed ID: 1321043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and activities of constrained analogues of human parathyroid hormone and parathyroid hormone-related peptide: implications for receptor-activating conformations of the hormones.
    Barbier JR; MacLean S; Morley P; Whitfield JF; Willick GE
    Biochemistry; 2000 Nov; 39(47):14522-30. PubMed ID: 11087406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
    Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13.
    Peggion E; Mammi S; Schievano E; Silvestri L; Schiebler L; Bisello A; Rosenblatt M; Chorev M
    Biochemistry; 2002 Jun; 41(25):8162-75. PubMed ID: 12069609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.
    Desbuquois B; Krug F; Cuatrecasas P
    Biochim Biophys Acta; 1974 Mar; 343(1):101-20. PubMed ID: 4364124
    [No Abstract]   [Full Text] [Related]  

  • 53. Conformational determinants in receptor recognition of peptide hormones: interaction of parathyroid hormone with the glucagon receptor.
    Shah GV; Epand RM; Orlowski RC
    Mol Cell Endocrinol; 1987 Feb; 49(2-3):203-10. PubMed ID: 3030852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new approach to search for the bioactive conformation of glucagon: positional cyclization scanning.
    Ahn JM; Gitu PM; Medeiros M; Swift JR; Trivedi D; Hruby VJ
    J Med Chem; 2001 Sep; 44(19):3109-16. PubMed ID: 11543679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipolytic and adenyl-cyclase-stimulating activity of glucagon 1-6: comparison with glucagon derivatives chemically modified in the 7-29 sequence.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Oct; 2(10):819-24. PubMed ID: 7171745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase.
    Blache P; Kervran A; Dufour M; Martinez J; Le-Nguyen D; Lotersztajn S; Pavoine C; Pecker F; Bataille D
    J Biol Chem; 1990 Dec; 265(35):21514-9. PubMed ID: 2147684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of the mouse major histocompatibility complex, H-2, on liver adenylate cyclase activity and on glucagon binding to liver cell membranes.
    Lafuse W; Edidin M
    Biochemistry; 1980 Jan; 19(1):49-54. PubMed ID: 6243475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ligand-mediated internalization of glucagon receptors in intact rat liver.
    Authier F; Desbuquois B; De Galle B
    Endocrinology; 1992 Jul; 131(1):447-57. PubMed ID: 1319325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guanosine 5'-triphosphate and guanosine 5'-[beta gamma-imido]triphosphate effect a collision coupling mechanism between the glucagon receptor and catalytic unit of adenylate cyclase.
    Houslay MD; Dipple I; Elliott KR
    Biochem J; 1980 Mar; 186(3):649-58. PubMed ID: 6249258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transfer of glucagon receptor from liver membranes to a foreign adenylate cyclase by a membrane fusion procedure.
    Schramm M
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1174-8. PubMed ID: 220608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.